Provided by Tiger Trade Technology Pte. Ltd.

COMPASS Pathways plc

6.59
-0.1500-2.23%
Post-market: 6.600.0100+0.15%19:35 EST
Volume:1.37M
Turnover:9.05M
Market Cap:632.75M
PE:-2.41
High:6.84
Open:6.80
Low:6.52
Close:6.74
52wk High:7.13
52wk Low:2.25
Shares:96.02M
Float Shares:58.41M
Volume Ratio:0.75
T/O Rate:2.35%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.7367
EPS(LYR):-2.2987
ROE:-205.81%
ROA:-38.43%
PB:16.83
PE(LYR):-2.87

Loading ...

Company Profile

Company Name:
COMPASS Pathways plc
Exchange:
NASDAQ
Establishment Date:
2020
Employees:
166
Office Location:
33 Broadwick Street,London,Greater London,United Kingdom
Zip Code:
W1F 0DQ
Phone:
- -
Fax:
- -
Introduction:
COMPASS Pathways plc operates as a mental health care company primarily in the United Kingdom and the United States. It develops COMP360, a psilocybin therapy that is in Phase III clinical trials for the treatment of treatment-resistant depression; and is in Phase II clinical trials for the treatment of post-traumatic stress disorder and anorexia nervosa. The company was formerly known as COMPASS Rx Limited and changed its name to COMPASS Pathways plc in August 2020. COMPASS Pathways plc was incorporated in 2020 and is headquartered in London, the United Kingdom.

Directors

Name
Position
Kabir Nath
Chief Executive Officer and Director
Gino Santini
Chair of the Board
Annalisa Jenkins
Director
Daphne Karydas
Director
David York Norton
Director
Jeff Jonas
Director
Justin Gover
Director
Linda McGoldrick
Director
Robert McQuade
Director
Wayne Riley
Director

Shareholders

Name
Position
Kabir Nath
Chief Executive Officer and Director
Teri Loxam
Chief Financial Officer
Guy Goodwin
Chief Medical Officer